Awards for “TEVA PHARMACEUTICALS USA, INC.”
25 awards on this page · sorted by amount · page 7
| Award ID | Recipient | Awarding agency | Amount | Start | End | NAICS | Description |
|---|---|---|---|---|---|---|---|
| SPE2DP21F2625 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-03-10 | 2021-03-23 | 325412 | 8508045034!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1549 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-01-14 | 2021-01-26 | 325412 | 8507913577!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1535 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-01-14 | 2021-01-26 | 325412 | 8507913381!ADENOVIRUS TYPE 4 A |
| SPE2DP21F1534 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $564.71K | 2021-01-14 | 2021-01-26 | 325412 | 8507913256!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0999 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-12-07 | 2020-12-15 | 325412 | 8507846171!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0376 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-11-03 | 2020-11-17 | 325412 | 8507773376!ADENOVIRUS TYPE 4 A |
| SPE2DP21F0374 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-11-03 | 2020-11-17 | 325412 | 8507773372!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7219 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-09-21 | 2020-09-29 | 325412 | 8507666397!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7218 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-09-21 | 2020-09-29 | 325412 | 8507666396!ADENOVIRUS TYPE 4 A |
| SPE2DP20F7217 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-09-21 | 2020-09-29 | 325412 | 8507666394!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6742 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-08-19 | 2020-08-25 | 325412 | 8507594799!ADENOVIRUS TYPE 4 A |
| SPE2DP20F6738 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-08-19 | 2020-08-25 | 325412 | 8507594791!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5010 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-05-21 | 2020-05-28 | 325412 | 8507395377!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5009 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-05-21 | 2020-05-28 | 325412 | 8507395375!ADENOVIRUS TYPE 4 A |
| SPE2DP20F5007 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-05-21 | 2020-05-28 | 325412 | 8507395372!ADENOVIRUS TYPE 4 A |
| SPE2DP20F2433 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-02-07 | 2020-02-11 | 325412 | 8507153557!ADENOVIRUS TYPE 4 A |
| SPE2DP20F2431 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-02-07 | 2020-02-11 | 325412 | 8507153553!ADENOVIRUS TYPE 4 A |
| SPE2DP20F2429 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $542.99K | 2020-02-07 | 2020-02-11 | 325412 | 8507153550!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5473 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $515.29K | 2026-05-11 | 2026-05-19 | 325412 | 8512097419!ADENOVIRUS TYPE 4 A |
| SPE2DP26F5471 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $515.29K | 2026-05-11 | 2026-05-19 | 325412 | 8512097411!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4639 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $515.29K | 2026-04-15 | 2026-04-29 | 325412 | 8512042110!ADENOVIRUS TYPE 4 A |
| SPE2DP26F4637 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $515.29K | 2026-04-15 | 2026-04-29 | 325412 | 8512042008!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8213 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-06-16 | 2025-06-24 | 325412 | 8511446662!ADENOVIRUS TYPE 4 A |
| SPE2DP25F8211 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-06-16 | 2025-06-24 | 325412 | 8511446497!ADENOVIRUS TYPE 4 A |
| SPE2DP25F6740 | TEVA PHARMACEUTICALS USA, INC. | Department of Defense | $495.47K | 2025-05-12 | 2025-05-20 | 325412 | 8511369472!ADENOVIRUS TYPE 4 A |